Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. 9B19M119
Authors: David Wood; Ken Mark
Published by: Ivey Publishing
Originally published in: 2019
Version: 2019-09-27
Revision date: 18-Oct-2019
Length: 11 pages
Data source: Published sources

Abstract

Rite Aid Corporation (Rite Aid) shareholders had turned down a USD3 million bonus proposed for the chief executive officer (CEO) and elected a new board chair. Under the CEO's leadership, Rite Aid had paid off some debt and returned to modest profitability. However, two failed plans to sell the business had shaken the shareholders' confidence. Having dealt with falling sales, shrinking profits, the sale of over half of its stores, and the news that Amazon.com Inc. had acquired an online pharmacy, Rite Aid was facing challenges from all sides. The drugstore industry was in turmoil, and without a buyer, the board chair needed to revisit the company's strategy and its management's capabilities. In the face of consolidation, vertical integration, and disruption from new entrants, survival was uncertain. Could Rite Aid survive on its own? Would it be feasible to attempt a third merger agreement, or were more radical options needed?
Location:
Industry:
Size:
Large
Other setting(s):
2018

About

Abstract

Rite Aid Corporation (Rite Aid) shareholders had turned down a USD3 million bonus proposed for the chief executive officer (CEO) and elected a new board chair. Under the CEO's leadership, Rite Aid had paid off some debt and returned to modest profitability. However, two failed plans to sell the business had shaken the shareholders' confidence. Having dealt with falling sales, shrinking profits, the sale of over half of its stores, and the news that Amazon.com Inc. had acquired an online pharmacy, Rite Aid was facing challenges from all sides. The drugstore industry was in turmoil, and without a buyer, the board chair needed to revisit the company's strategy and its management's capabilities. In the face of consolidation, vertical integration, and disruption from new entrants, survival was uncertain. Could Rite Aid survive on its own? Would it be feasible to attempt a third merger agreement, or were more radical options needed?

Settings

Location:
Industry:
Size:
Large
Other setting(s):
2018

Related